期刊文献+

非小细胞肺癌脑转移的放射治疗——附32例报告

Palliative radiotherapy combined with chemotherapy for non-small cell lung cancer with synchronous brain metastasis
下载PDF
导出
摘要 收集 1995年 6月~ 2 0 0 2年 6月非小细胞肺癌 (non smallcelllungcancer ,NSCLC)脑转移住院患者 3 2例 ,采用放疗或放疗加化疗等综合性治疗 (颅内转移病灶采用全颅二侧野对穿照射 ,中线剂量 :3 0~ 40Gy/15~ 2 0次 ,后缩野追加肿瘤量 16~ 2 0Gy/8~ 10次 ,同时给EP、NP等方案化疗的综合方法治疗 )观察其疗效。初步研究结果提示 ,所有患者在顺利完成治疗后 ,平均存活期达 7个月。肺癌脑转移采用放疗、化疗的综合治疗 ,可延长生存时间 。 From 1995.6 to 2002.6 , 32 cases of non-small cell lung cancer complicated with brain metastasis were administrated with radiotherapy or radiotherapy combined with chemotherapy and other modality therapy.All patients were radioted with two lateral fields by 6 MV X-ray.After the prercription dose of 30-40 Gy/15-20 F,small frelds were taken to boast with tumor dose 16-20 Gy/8-10 F.The chemotherapy regimens were EP (Vp-16+DDP) or NP(NVB+DDP). All patients had been treated successfully and the mean survival time was over seven months.This modality therapy can prolong the patients' survival time and improve the living quality.
出处 《肿瘤防治杂志》 2004年第3期309-310,共2页 China Journal of Cancer Prevention and Treatment
关键词 脑肿瘤/继发性 脑肿瘤/放射疗法 脑肿瘤/综合疗法 carcinoma,non-small cell lung brain neoplasms/secondary brain neoplasms/radiotherapy brain neoplasms/combined modality therapy
  • 相关文献

参考文献4

二级参考文献20

  • 1Posner J . Management of the brain meatastases[J]. Rev Neurol, 1992, 148(6-7): 477-487.
  • 2Agboola O, Brien B, Silva B, et al. Prognostic factors derived from recursive partition Analysis(RPA) of Radioation Therapy Oncology Group(RTOG) brain meatastases trails applied to surgically resected and irradiated brain meatastases cases[J]. Int J Radiat Oncol Biol Phys, 1998, 42(1): 155-159.
  • 3Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis(RPA) of factors in three Radiation Therapy Oncology Group(RTOG) brain metastases trials[J]. Int J Radiat Oncol Biol Phys, 1997, 37(4): 745-751.
  • 4Postmus P, Smit E, Haaxma Reiche H, et al. Teniposide for brain metastases of small-cell lung cancer: a phase Ⅱ study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group[J]. J Clin Oncol, 1995, 13(3): 660-665.
  • 5Grossi F, Scolaro T, Tixi L, et al. The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer[J]. Crit Rev Oncol Hematol, 2001, 37(1): 61-67.
  • 6Schutte W, Manegold C, von Pawel J, et al. Topotecan——a new treatment option in the therapy of brain metastases of lung cancer[J]. Front Radiat Ther Oncol, 1999, 33: 354-363.
  • 7Boogerd W, van der Sande J, van Zandwijk N, et al. Teniposide sometimes effective in brain metastases from non-small cell lung cancer[J]. J Neurooncol, 1999, 41(3): 285-289.
  • 8Cotto C, Berille J, Souquet PJ, et al. A phase Ⅱ trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer[J]. Eur J Cancer, 1996, 32A(1): 69-71.
  • 9Fujita A, Fukuoka S, Takabatake H, et al. Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer[J]. Ontology, 2000, 59(4): 291-295.
  • 10Minotti V, Crino L, Meacci M, et al. Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer[J]. Lung Cancer, 1998, 20(2): 93-98.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部